Who
Todd C. Girolamo
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, ProKidney; Director, Longeveron; CLO, SVP of Corp Dev, Lisata Therapeutics.
In numbers
- Trades disclosed
- 29
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 10 Jan 2022
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyBiotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PROK ProKidneyBiotechnology | SEC FORM 4 Code C | —163,857 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 1 Mar 2026filed 3 Mar 2026 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —650,000 at $0.00 | filing |
| 31 Jul 2024filed 2 Aug 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 31 Jul 2024filed 2 Aug 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 31 Jul 2024filed 2 Aug 2024 | PROK ProKidneyBiotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 1 Mar 2024filed 5 Mar 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —234,742 at $0.00 | filing |
| 5 Feb 2024filed 6 Feb 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 5 Feb 2024filed 6 Feb 2024 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 5 Feb 2024filed 6 Feb 2024 | PROK ProKidneyBiotechnology | SEC FORM 4 Code C | —81,928 at $0.00 | filing |
| 16 Jan 2023filed 18 Jan 2023 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —290,000 at $0.00 | filing |
| 21 Dec 2022filed 22 Dec 2022 | LGVN Longeveronoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 20 Oct 2022filed 24 Oct 2022 | PROK ProKidneyoption or derivative · Biotechnology | SEC FORM 4 Code A | —696,793 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.